1. Home
  2. TSN vs NTRA Comparison

TSN vs NTRA Comparison

Compare TSN & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$56.86

Market Cap

19.7B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.52

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSN
NTRA
Founded
1935
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TSN
NTRA
Price
$56.86
$244.52
Analyst Decision
Hold
Strong Buy
Analyst Count
10
16
Target Price
$61.70
$227.69
AVG Volume (30 Days)
3.7M
1.7M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
1.33
N/A
Revenue
$54,441,000,000.00
$2,116,676,000.00
Revenue This Year
$4.28
$32.77
Revenue Next Year
$0.76
$16.51
P/E Ratio
$42.87
N/A
Revenue Growth
2.12
38.17
52 Week Low
$50.56
$125.38
52 Week High
$64.36
$245.59

Technical Indicators

Market Signals
Indicator
TSN
NTRA
Relative Strength Index (RSI) 59.59 80.03
Support Level $52.65 $233.67
Resistance Level $58.67 $240.18
Average True Range (ATR) 1.27 7.39
MACD 0.14 0.68
Stochastic Oscillator 69.93 97.49

Price Performance

Historical Comparison
TSN
NTRA

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each composing about one third of US sales. Prepared foods constituted 18% of fiscal 2024 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: